N/A
Loading page data
Please wait a moment
Search Report
Loading page data
Please wait a moment
Many drugs are administered through injection for maintenance and induction of anesthesia. Anesthesia is administered in the body by combination of injectable drugs with inhalation agents for long span of time or, exclusively with injectable anesthesia drugs for shorter span of time.
Injectable anesthesia helps to numb the particular area of the body by dismissing or blocking any kind of painful signal from being communicated to the brain. Injectable anesthesia are highly preferred for surgical procedures, among which the most common applications are, during labor, dental procedures and different other operative procedures.
The most standard injectable anesthesia drug to which most other injectable anesthesia drugs are compared in thiopental. A few anesthesia adjuvant drugs are considered to be vital to contemporary discussion of injectable anesthesia re alpha-2 adrenergic and benzodiazepine agents. Regional injectable anesthesia is highly performed to provide more comfort during and after any operative procedure.
Increase in number of dental procedures, and other surgical procedures that require anesthesia is expected to fuel the market growth for injectable anesthesia. Rapid rise in aging population, increase in number of local manufacturers for injectable anesthesia drugs and increasing prevalence of several respiratory system-related and cardiovascular diseases is also projected to boost the demand for injectable anesthesia.
There is a consistent growth in number of emergency surgeries performed every year, worldwide. This is further expected to contribute to the growth of the injectable anesthesia market during the forecast years. However, there are certain side-effects related to injectable anesthesia drugs, such as, elevation in heart rate and blood pressure, respiratory depression, amnesia, and different types of hallucinations
. These side effects, low compliance rates of injectable anesthesia drugs, mortality rate related with the overuse of injectable anesthesia and various other regulatory issues with injectable anesthesia drugs is expected to obstruct market growth for injectable anesthesia during the forecast period.
The US Injectable Anesthesia market is projected to witness a robust growth in the North American market for injectable anesthesia owing it to the increase in number of surgical procedures and huge number of manufacturer presence for injectable anesthesia drugs in the region. Asia-Pacific’s injectable anesthesia market and Europe’s market for injectable anesthesia drugs is also expected to grow at a significant rate during the forecast period because of the increase in prevalence for respiratory system-related and cardiovascular disorders.
Increase in healthcare expenditure and improved healthcare infrastructure in also expected to boost demand for injectable anesthesia in the region. MEA Injectable Anesthesia market is expected to witness decent growth owing it to less per capita income resulting in less affordability and poor healthcare infrastructure resulting in less availability of injectable anesthesia during surgical procedures.
Some of the market participants in the Global Injectable Anesthesia market identified across the value chain include Abbott, Baxter, F. Hoffmann-La Roche, AstraZeneca, B. Braun Melsungen AG, AbbVie Inc, Fresenius SE & Co. KgaA, Eisai Co., Ltd., Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Teva Pharmaceuticals, Novartis AG, Sagent Pharmaceutical, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Mylan N.V., and Par Pharmaceutical.
